Correction to: Neutralization of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Reduces Spinal Cord Injury Damage in Mice (Neuropsychopharmacology, (2010), 35, 6, (1302-1314), 10.1038/npp.2009.234);Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice

Neuropsychopharmacology

Volumn 35, Issue 6, 2010, Pages 1302-1314

  Cantarella, Giuseppina ^a   Di Benedetto, Giulia ^a,b   Scollo, Mimmo ^a   Paterniti, Irene ^c   Cuzzocrea, Salvatore ^c   Bosco, Paolo ^b   Nocentini, Giuseppe ^d   Riccardi, Carlo ^d   Bernardini, Renato ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Cytokines; GITR GITRL; Immunoneutralization; Neuroinflammation; Neuronal death; Pharmacological treatment

Indexed keywords

CASPASE 3; CASPASE 8; FAS LIGAND; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 1BETA; PROTEIN BAX; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; ENZYME ACTIVATION; GRAY MATTER; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; WESTERN BLOTTING; WHITE MATTER;

EID: 77951106793     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/s41386-023-01768-0     Document Type: Erratum

References (60)

1. Almasan A, Ashkenazi A (2003). Apo2L/TRAIL: apoptosis signal-ling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14: 337-348.
2. Aktas O, Schulze-Topphoff U, Zipp F (2007). The role of TRAIL/TRAIL receptors in central nervous system pathology. Front Biosci 12: 2912-2921.
3. Ashkenazi A, Dixit VM (1998). Death receptors: signalling and modulation. Science 281: 1305-1308.
4. Basso DM, Beattie MS, Bresnahan JC (1995). A sensitive and reliable locomotor ratting scale for open field testing in rats. J Neurotrauma 12: 1-21.
5. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. Cantarella G, Lempereur L, D'Alcamo MA, Risuglia N, Cardile V, Pennisi G et al (2007). Trail interacts redundantly with nitric oxide in rat astrocytes: potential contribution to neurodegen-erative processes. J Neuroimmunol 182: 41-47.
7. Cantarella G, Uberti D, Carsana T, Lombardo G, Bernardini R, Memo M (2003). Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity. Cell Death Differ 10: 134-141.
8. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L (1998). Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151: 77-88.
9. Chatham WW, Swaim R, Frohsin Jr H, Heck LW, Miller EJ, Blackburn Jr WD (1993). Degradation of human articular cartilage by neutrophils in synovial fluid. Arthritis Rheum 36: 51-58.
10. Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D et al (2006). TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest 116: 2493-2499.
11. Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C et al (2004). Neutralization of CD95 ligand promotes regenera-tion and functional recovery after spinal cord injury. Nat Med 10: 389-395.
12. DeVivo MJ, Rutt RD, Stover SL, Fine PR (1987). Employment after spinal cord injury. Arch Phys Med Rehabil 68: 494-498.
13. Dörr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH et al (2002). Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J Neurosci 22: RC209.
14. Ekshyyan O, Aw TY (2004). Apoptosis in acute and chronic neurological disorders. Front Biosci 9: 1567-1576.
15. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD et al (2006). The cellular inflammatory response in human spinal cords after injury. Brain 129: 3249-3269.
16. Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muià C, Esposito E et al (2008). TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock 29: 32-41.
17. Genovese T, Mazzon E, Di Paola R, Cannavo G, Muia C, Bramanti P et al (2005). Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma. Exp Neurol 194: 267-278.
18. Harrington JF, Messier AA, Levine A, Szmydynger-Chodobska J, Chodobski A (2005). Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury. J Neurotrauma 22: 919-928.
19. Hausmann ON (2003). Post-traumatic inflammation following spinal cord injury. Spinal Cord 41: 369-378.
20. Jaganathan J, Petit JH, Lazio BE, Singh SK, Chin LS (2002). Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines. Neurosurg Focus 13: ecp1.
21. Joshi M, Fehlings MG (2002a). Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma 19: 175-190.
22. Joshi M, Fehlings MG (2002b). Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J Neurotrauma 19: 191-203.
23. Jurewicz A, Matysiak M, Andrzejak S, Selmaj K (2006). TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway. Glia 53: 158-166.
24. Krausz LT, Bianchini R, Ronchetti S, Fettucciari K, Nocentini G, Riccardi C (2007). GITR-GITRL system, a novel player in shock and inflammation. ScientificWorldJournal 7: 533-566.
25. Lee YB, Yune TY, Baik SY, Shin YH, Du S, Rhim H et al (2000). Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury. Exp Neurol 166: 190-195.
26. Li GL, Farooque M, Olsson Y (2000). Changes of Fas and Fas ligand immunoreactivity after compression trauma to rat spinal cord. Acta Neuropathol 100: 75-81.
27. Liu D, Xu GY, Pan E, McAdoo DJ (1999). Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience 93: 1383-1389.
28. Lu J, Ashwell KW, Waite P (2000). Advances in secondary spinal cord injury: role of apoptosis. Spine 25: 1859-1866.
29. Martin-Ventura JL, Munoz-Garcia B, Egido J, Blanco-Colio LM (2007). TRAIL and vascular injury. Front Biosci 12: 3656-3667.
30. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J et al (1999). CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 19: 3809-3817.
31. Mullane K (1989). Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog Clin Biol Res 301: 39-51.
32. Nocentini G, Riccardi C (2009). GITR: a modulator of immune response and inflammation. Adv Exp Med Biol 647: 156-173.
33. Nocentini G, Cuzzocrea S, Genovese T, Bianchini R, Mazzon E, Ronchetti S et al (2008). Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury. Mol Pharmacol 73: 1610-1621.
34. Nocentini G, Ronchetti S, Cuzzocrea S, Riccardi C (2007). GITR/GITRL: more than an effector T cell co-stimulatory system. Eur J Immunol 37: 1165-1169.
35. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM (1997a). An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815-818.
36. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J et al (1997b). The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113.
37. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687-12690. (Pubitemid 26175834)
38. Plunkett JA, Yu CG, Easton JM, Bethea JR, Yezierski RP (2001). Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol 168: 144-154.
39. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S (2004). Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 15: 415-436.
40. Razmara M, Hilliard B, Ziarani AK, Murali R, Yellayi S, Ghazanfar M et al (2009). Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomye-litis. Am J Pathol 174: 460-474.
41. Rivlin AS, Tator CH (1978). Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 10: 38-43.
42. Robertson J, Beaulieu JM, Doroudchi MM, Durham HD, Julien JP, Mushynski WE (2001). Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J Cell Biol 155: 217-226.
43. Ronchetti S, Nocentini G, Bianchini R, Krausz LT, Migliorati G, Riccardi C (2007). Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells. J Immunol 179: 5916-5926.
44. Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, Nocentini G et al (2004). GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopu-lations. Eur J Immunol 34: 613-622.
45. Satoh JI, Kuroda Y (2001). Alpha-synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic factors. Parkinsonism Relat Disord 8: 7-17.
46. Shea TB (1994). Technical report. An inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner. Biotechniques 16: 1126-1128.
47. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D et al (1997). Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818-821.
48. Springer JE, Azbill RD, Knapp PE (1999). Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med 5: 943-946.
49. Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT (1998). Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 152: 74-87.
50. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M et al (1997). Role of neutrophils in spinal cord injury in the rat. Neuroscience 79: 1177-1182.
51. Tator CH (1995). Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 5: 407-413.
52. Tator CH, Koyanagi I (1997). Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 86: 483-492.
53. Tone M, Tone Y, Adams E, Yates SF, Frewin MR, Cobbold SP et al (2003). Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc Natl Acad Sci USA 100: 15059-15064.
54. Uberti D, Cantarella G, Facchetti F, Cafici A, Grasso G, Bernardini R et al (2004). TRAIL is expressed in the brain cells of Alzheimer's disease patients. Neuroreport 15: 579-581.
55. Uberti D, Ferrari-Toninelli G, Bonini SA, Sarnico I, Benarese M, Pizzi M et al (2007). Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. Neuropsychopharmacology 32: 872-880.
56. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N et al (1997). TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 16: 5386-5397.
57. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK et al (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682.
58. Xu J, Fan G, Chen S, Wu Y, Xu XM, Hsu CY (1998). Methyl-prednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. Brain Res Mol Brain Res 59: 135-142.
59. Yu WR, Liu T, Fehlings TK, Fehlings MG (2009). Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury. Eur J Neurosci 29: 114-131.
60. Zurita M, Vaquero J, Zurita I (2001). Presence and significance of CD-95 (Fas/APO1) expression after spinal cord injury. J Neurosurg 94: 257-264.